In PD-L1 TC- and IC- negative ICC, 50% (55/110) and 51.2% (65/127) patients were observed to express elevated HHLA2, respectively (Fig. 1e). This evidence concerns the gene HHLA2 and intrahepatic cholangiocarcinoma.